Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 3091 AL 3105

Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease

Ferraye MU, Debû B, Fraix V, Goetz L, Ardouin C, Yelnik J, Henry-Lagrange C, Seigneuret E, Piallat B, Krack P, Le Bas JF, Benabid AL, Chabardès S, Pollak P.

Brain. 2010 Jan;133(Pt 1):205-14. doi: 10.1093/brain/awp229. Epub 2009 Sep 22.

Cerebellum can be a possible generator of progressive myoclonus

Koh KN, Lim BC, Hwang H, Park JD, Chae JH, Kim KJ, Hwang YS, Kim SK, Wang KC, Moon HK.

J Child Neurol. 2010 Jun;25(6):728-31. doi: 10.1177/0883073809342273. Epub 2009 Sep 22.

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.

Int J Neuropsychopharmacol. 2010 Aug;13(7):861-76. doi: 10.1017/S1461145709990605. Epub 2009 Sep 29.

Magnetoencephalographic findings in two cases of juvenile myoclonus epilepsy

Kotini A, Mavraki E, Anninos P, Piperidou H, Prassopoulos P.

Brain Topogr. 2010 Mar;23(1):41-5. doi: 10.1007/s10548-009-0114-5. Epub 2009 Sep 29.

Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome

Rossi S, Ulivelli M, Malentacchi M, Greco G, Bartalini S, Borgogni P, Giannini F.

J Neurol. 2010 Feb;257(2):281-5. doi: 10.1007/s00415-009-5331-z. Epub 2009 Oct 10.

Clozapine-induced myoclonus: a case study and brief review

Praharaj SK, Venkatesh BG, Sarkhel S, Zia-ul-Haq M, Sinha VK.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):242-3. doi: 10.1016/j.pnpbp.2009.10.006. Epub 2009 Oct 13.

Effect of apomorphine on cognitive performance and sensorimotor gating in humans

Schellekens AF, Grootens KP, Neef C, Movig KL, Buitelaar JK, Ellenbroek B, Verkes RJ.

Psychopharmacology (Berl). 2010 Jan;207(4):559-69. doi: 10.1007/s00213-009-1686-1. Epub 2009 Oct 16.

Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus

Pranzatelli MR, Tate ED, Travelstead AL, Colliver JA.

J Clin Immunol. 2010 Jan;30(1):106-13. doi: 10.1007/s10875-009-9335-3. Epub 2009 Oct 17.

Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases

Mijajlovic M, Mirkovic M, Dackovic J, Zidverc-Trajkovic J, Sternic N.

J Neurol Sci. 2010 Jan 15;288(1-2):194-6. doi: 10.1016/j.jns.2009.09.030. Epub 2009 Oct 28.

Overgeneralization of conditioned fear as a pathogenic marker of panic disorder

Lissek S, Rabin S, Heller RE, Lukenbaugh D, Geraci M, Pine DS, Grillon C.

Am J Psychiatry. 2010 Jan;167(1):47-55. doi: 10.1176/appi.ajp.2009.09030410. Epub 2009 Nov 16.

Gabapentin therapy for ocular opsoclonus-myoclonus restores eye movement communication in a patient with a locked-in syndrome

Pistoia F, Sarà M.

Neurorehabil Neural Repair. 2010 Jun;24(5):493-4. doi: 10.1177/1545968309353330. Epub 2009 Nov 20.

Epileptic lingual myoclonus associated with cavernoma

Li JY, Chen CC, Lee CH.

Mov Disord. 2010 Jan 30;25(2):250-1. doi: 10.1002/mds.22892.

Correspondence: A further case of opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection

Shiihara T, Takahashi Y.

Eur J Pediatr. 2010 May;169(5):639; author reply 641. doi: 10.1007/s00431-009-1105-y. Epub 2009 Nov 27.

CT perfusion evidence of early global cerebral hypoperfusion after aneurysmal subarachnoid hemorrhage with cardiac arrest

Burns JD, Jacob JT, Luetmer PH, Wijdicks EF.

Neurocrit Care. 2010 Apr;12(2):261-4. doi: 10.1007/s12028-009-9297-6.

The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics

Inagaki H, Kiyokawa Y, Takeuchi Y, Mori Y.

Pharmacol Biochem Behav. 2010 Feb;94(4):575-9. doi: 10.1016/j.pbb.2009.11.013. Epub 2009 Dec 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias